Target Group Inc. (CBDY)
OTCMKTS · Delayed Price · Currency is USD
0.0012
+0.0003 (33.33%)
Aug 18, 2026, 9:30 AM EST
Target Group Revenue
Target Group had revenue of $1.38M in the quarter ending June 30, 2026, with 10.85% growth. This brings the company's revenue in the last twelve months to $3.50M, down -30.69% year-over-year. In the year 2025, Target Group had annual revenue of $3.88M, down -41.12%.
Revenue (ttm)
3.50M
Revenue Growth
-30.69%
P/S Ratio
0.16
Revenue / Employee
n/a
Employees
42
Market Cap
555.32K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.88M | -2.71M | -41.12% |
| Dec 31, 2024 | 6.59M | 2.87M | 77.19% |
| Dec 31, 2023 | 3.72M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 373.80M |
| Tian'an Pharmaceutical | 10.65M |
| Cannabis Global | 1.06M |
| LiveWire Ergogenics | 571.68K |
| Nutra Pharma | 323.13K |
| Anything Technologies Media | 257.70K |
| Sky Century Investment | 126.22K |
| CBD Life Sciences | 98.32K |